• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类中安非他命的行为效应:亚临床水平的注意力不集中和多动的影响。

Behavioral effects of d-amphetamine in humans: influence of subclinical levels of inattention and hyperactivity.

机构信息

Department of Behavioral Science, University of Kentucky Chandler Medical Center, Lexington, Kentucky 40536-0086, USA.

出版信息

Am J Drug Alcohol Abuse. 2010 Jul;36(4):220-7. doi: 10.3109/00952990.2010.494213.

DOI:10.3109/00952990.2010.494213
PMID:20560842
Abstract

OBJECTIVE

Several studies suggest a link between stimulant abuse and attention-deficit hyperactivity disorder (ADHD) symptoms (e.g., inattention and hyperactivity). To further assess the nature of this relationship, the present study examined the association between subclinical symptoms of inattention and hyperactivity and the behavioral effects of d-amphetamine.

METHODS

Participants were classified into a High- (n = 8) or Low-Score (n = 9) group based on their responses on a rating scale that assessed inattention and hyperactivity symptoms.

RESULTS

The participants did not differ across the High-Score and Low-Score groups in their ability to discriminate d-amphetamine. The participants in the High-Score group were significantly more sensitive to the positive participant-rated effects of d-amphetamine (e.g., Good Effects, Like Drug), but less sensitive to drug-induced increases in blood pressure and heart rate.

CONCLUSION

The selective increase in positive subjective effects of d-amphetamine suggests that individuals with subclinical inattention and hyperactivity symptoms may have increased vulnerability to stimulant abuse.

摘要

目的

多项研究表明,兴奋剂滥用与注意力缺陷多动障碍(ADHD)症状之间存在关联(例如,注意力不集中和多动)。为了进一步评估这种关系的本质,本研究探讨了亚临床注意力不集中和多动症状与 d-苯丙胺的行为效应之间的关联。

方法

根据评估注意力不集中和多动症状的评分量表上的反应,将参与者分为高分(n = 8)或低分(n = 9)组。

结果

高分组和低分组在区分 d-苯丙胺的能力方面没有差异。高分组的参与者对 d-苯丙胺的积极自评效应(例如,良好效应,喜欢药物)更为敏感,但对血压和心率升高的药物诱导反应则不太敏感。

结论

d-苯丙胺的积极主观效应选择性增加表明,亚临床注意力不集中和多动症状的个体可能对兴奋剂滥用的易感性增加。

相似文献

1
Behavioral effects of d-amphetamine in humans: influence of subclinical levels of inattention and hyperactivity.人类中安非他命的行为效应:亚临床水平的注意力不集中和多动的影响。
Am J Drug Alcohol Abuse. 2010 Jul;36(4):220-7. doi: 10.3109/00952990.2010.494213.
2
Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.奥沙西泮不会调节右旋苯丙胺对人类的行为影响。
Pharmacol Biochem Behav. 2005 Oct;82(2):270-9. doi: 10.1016/j.pbb.2005.08.012. Epub 2005 Sep 22.
3
Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.混合安非他明盐缓释剂(阿得拉XR)治疗青少年注意缺陷多动障碍的疗效与安全性:一项为期4周的随机、双盲、安慰剂对照平行组研究。
Clin Ther. 2006 Feb;28(2):266-79. doi: 10.1016/j.clinthera.2006.02.011.
4
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.注意缺陷多动障碍儿童及青少年从哌甲酯或苯丙胺转换为托莫西汀的初步耐受性和疗效研究
Clin Ther. 2007 Jun;29(6):1168-77. doi: 10.1016/j.clinthera.2007.06.017.
5
Individual differences in responses to ethanol and d-amphetamine: a within-subject study.乙醇和右旋苯丙胺反应的个体差异:一项受试者内研究。
Alcohol Clin Exp Res. 2001 Apr;25(4):540-8.
6
Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.缓释混合苯丙胺盐(安非他明XR)治疗学龄儿童和青少年对立违抗性障碍(伴或不伴注意力缺陷多动障碍共病)的疗效和安全性:一项为期4周的多中心、随机、双盲、平行组、安慰剂对照、强制剂量递增研究。
Clin Ther. 2006 Mar;28(3):402-18. doi: 10.1016/j.clinthera.2006.03.006.
7
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.哌醋甲酯治疗伴有多动的广泛性发育障碍的随机对照交叉试验
Arch Gen Psychiatry. 2005 Nov;62(11):1266-74. doi: 10.1001/archpsyc.62.11.1266.
8
Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.持续释放哌甲酯治疗苯丙胺滥用者注意缺陷多动障碍:一项初步研究。
Drug Alcohol Depend. 2010 Apr 1;108(1-2):130-3. doi: 10.1016/j.drugalcdep.2009.11.006. Epub 2009 Dec 16.
9
Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.右旋苯丙胺和莫达非尼对健康成年人的行为及主观影响。
Exp Clin Psychopharmacol. 2007 Apr;15(2):123-33. doi: 10.1037/1064-1297.15.2.123.
10
Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program.戒烟项目参与者中的注意力缺陷多动障碍(ADHD)症状与吸烟模式
Nicotine Tob Res. 2001 Nov;3(4):353-9. doi: 10.1080/14622200110072156.